Application Nr Approved Date Route Status External Links
ANDA091283 2012-11-28 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Tizanidine Is A Central Alpha-2-Adrenergic Agonist Indicated For The Management Of Spasticity. Because Of The Short Duration Of Therapeutic Effect, Treatment With Tizanidine Should Be Reserved For Those Daily Activities And Times When Relief Of Spasticity Is Most Important. (1) Tizanidine Is A Central Alpha-2-Adrenergic Agonist Indicated For The Management Of Spasticity. Because Of The Short Duration Of Therapeutic Effect, Treatment With Tizanidine Should Be Reserved For Those Daily Activities And Times When Relief Of Spasticity Is Most Important [see Dosage And Administration (2.1)].

All Formulated Excipients (2 Total)

Name Structure Kind Function Status
1. Silicon Dioxide SILICON DIOXIDE Unresolved AC-Anticaking agent , MISC-Miscellaneous , STAB-Stabilizer GRAS-Generally recognized as safe.
2. Stearic Acid STEARIC ACID Molecular MISC-Miscellaneous GRAS-Generally recognized as safe.

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Tizanidine Hydrochloride TIZANIDINE HYDROCHLORIDE ZINC19702309

Comments